Phase II study of everolimus (E) in refractory testicular germ cell tumors (TGCTs)

Category Primary study
JournalJournal of Clinical Oncology
Year 2015
This article has no abstract
Epistemonikos ID: d282eaa482231b02d6644a3392f823d1121abea5
First added on: Feb 07, 2025